⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GHRS News
GH Research PLC Ordinary Shares
GH Research Announces Pricing of $117.5 Million Underwritten Offering
globenewswire.com
GHRS
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
globenewswire.com
GHRS
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
globenewswire.com
GHRS
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
prnewswire.com
GHRS
HELP
DFTX
ATAI
CMPS
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
GHRS
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
prnewswire.com
GHRS
DFTX
HELP
ATAI
LBRX
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
globenewswire.com
GHRS
GH Research to Announce IND Status for GH001
globenewswire.com
GHRS
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
globenewswire.com
GHRS
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
globenewswire.com
GHRS